Drug profile · INN
valacyclovir hydrochloride
VALACYCLOVIR HYDROCHLORIDE
valacyclovir hydrochloride (VALACYCLOVIR HYDROCHLORIDE) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — valacyclovir hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 0
- Data quality
- 0.89
Quick answer
valacyclovir hydrochloride (VALACYCLOVIR HYDROCHLORIDE) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Human herpesvirus 1 DNA polymerase inhibitor
Primary target: DNA polymerase catalytic subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is valacyclovir hydrochloride?
valacyclovir hydrochloride (VALACYCLOVIR HYDROCHLORIDE) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for valacyclovir hydrochloride?
VALACYCLOVIR HYDROCHLORIDE is a marketed brand name for valacyclovir hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of valacyclovir hydrochloride?
valacyclovir hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.